Board of Directors

Board of Directors

Gun-Britt Fransson, chairman of the board since 2018

Gun-Britt Fransson has more than 30 years of experience in management, business development and R&D within biotechnology, food and drug development. Until 2018 Fransson worked as VP R&D at Probi AB. Previous experience includes CEO of Alligator Bioscience AB, Research Director at Orkla Foods A / S and research-leading positions at KabiPharmacia AB. Fransson has extensive experience in board work and has held positions as Chairman and Board member, in both private and public companies, foundations and universities.

Gun-Britt-Fransson

Shares in the company:
Fransson owns 53,333 shares

Fransson’s other assignments:

  • Lighthouse Life Science Consulting AB: Deputy
  • Lighthouse HB: Partner
  • MedicPen AB (publ): Board Member
  • Invent Medic Sweden AB: Board Member

Alejandra Mørk, member of the board since 2018

Alejandra Mørk is the CEO and main shareholder of KLIFO. Previously, she worked for Nycomed Pharma for 18 years, in various management positions in drug development and lifecycle management. Alejandra is a board member of Danish Biotech and a member of the Danish Academy of Technical Sciences. She is also part of the EUCROF Paediatric Working Group.

Alejandra_Moerk

Shares in the company:
No shares

Mørk’s other assignments:

  • iSD Immunotech ApS: Board Member
  • KLIFO Holding A/S: Board Member
  • KLIFO A/S: CEO

Lars H. Bruzelius, member of the board since 2013

Lars H. Bruzelius is an Associate Professor in Business Administration and a management consultant with large experience from various business areas, amongst other Medtech. Bruzelius has for example held the position as Vice President and Administrative Director at Gambro AB and founded, developed, owned and acted as the CEO for management consultant companies. Bruzelius has been a member of the board in several companies and acted as investor in several start- ups, primarily within life science.

lars-h-bruzelius-01

Shares in the company:
Bruzelius owns through Brushamn Invest Aktiebolag 2,798,047 shares.

Bruzelius other assignments:

  • Brushamn Holding Aktiebolag: Board Member
  • Brushamn Invest Aktiebolag: Board Member
  • Catella Fondförvaltning AB: Board Member
  • Lunds universitets stipendiestiftelse: Board Member

Carl-Johan Spak, member of the board since 2019

Carl-Johan Spak is Senior Advisor at Flerie Invest. During 2009 and 2020, he held several senior positions at Recipharm, the latest as CEO at Recipharm Venture Fund AB. He has more than 30 years’ experience in pharmaceutical industry with positions as managing director and CEO in small startup companies as well as larger pharmaceutical companies. Carl-Johan has a PhD in dentistry and pharmacology.

Carl-Johan Spak, Member of the Board, Follicum

Shares in the company:
No shares.

Spak’s other assignments:

  • Pharmacolog i Uppsala AB, Board Member
  • Symcel Sverige AB, Board Member
  • Empros Pharma AB, Board Member
  • Atrogi AB, Board Member
  • Prokarium Ltd, Board Member
  • Prokarium Holdings Ltd, Board Member
  • Kahr Medical Ltd, Board Member
  • Sweden-BIO Service AB, Board Member
  • Xspray AB, Board Member
  • Buzzard Pharmaceuticals AB, Deputy Board Member